{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:11:17Z","timestamp":1792512677081,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,9]]},"DOI":"10.7759\/cureus.87574","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T11:57:33Z","timestamp":1752062253000},"source":"Crossref","is-referenced-by-count":4,"title":["Comparison of Levetiracetam Versus Sodium Valproate as a Monotherapy in Early Childhood Epilepsy"],"prefix":"10.7759","author":[{"given":"Zainab","family":"Latif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Memoona","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem Farooq","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohaib","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz Muhammad Zeeshan","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1718718","article-title":"Acute seizures\u2014Work-up and management in children","volume":"40","author":"Romantseva L","year":"2020","unstructured":"Romantseva L, Lin N. Acute seizures\u2014Work-up and management in children. Semin Neurol. 2020, 40:606-16. 10.1055\/s-0040-1718718","journal-title":"Semin Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fepid.2023.1273163","article-title":"Editorial: Epidemiology of epilepsy and seizures","volume":"3","author":"Chen Z","year":"2023","unstructured":"Chen Z, Brodie MJ, Ding D, Kwan P. Editorial: Epidemiology of epilepsy and seizures. Front Epidemiol. 2023, 3:1273163. 10.3389\/fepid.2023.1273163","journal-title":"Front Epidemiol"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies","volume":"88","author":"Fiest KM","year":"2017","unstructured":"Fiest KM, Sauro KM, Wiebe S, et al.. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology. 2017, 88:296-303.","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2021.01.038","article-title":"Epilepsy: A clinical overview","volume":"134","author":"Milligan TA","year":"2021","unstructured":"Milligan TA. Epilepsy: A clinical overview. Am J Med. 2021, 134:840-7. 10.1016\/j.amjmed.2021.01.038","journal-title":"Am J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.670958","article-title":"Treatment for the benign childhood epilepsy with centrotemporal spikes: A monocentric study","volume":"12","author":"Kessi M","year":"2021","unstructured":"Kessi M, Yan F, Pan L, et al.. Treatment for the benign childhood epilepsy with centrotemporal spikes: A monocentric study. Front Neurol. 2021, 12:670958. 10.3389\/fneur.2021.670958","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3934\/medsci.2021013","article-title":"Single and in combination antiepileptic drug therapy in children with epilepsy: How to use it","volume":"8","author":"Oliva CF","year":"2021","unstructured":"Oliva CF, Gangi G, Marino S, et al.. Single and in combination antiepileptic drug therapy in children with epilepsy: How to use it. AIMS Med Sci. 2021, 8:138-46. 10.3934\/medsci.2021013","journal-title":"AIMS Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2024.78.122-126","article-title":"Efficacy and safety of levetiracetam for childhood epilepsies","volume":"78","author":"Catibusic FH","year":"2024","unstructured":"Catibusic FH, Uzicanin S, Salihbegovic EV, Huseinbegovic Z. Efficacy and safety of levetiracetam for childhood epilepsies. Med Arch. 2024, 78:122-6. 10.5455\/medarh.2024.78.122-126","journal-title":"Med Arch"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/08830738198468","article-title":"Effectiveness of levetiracetam monotherapy in pediatric patients with epilepsy","volume":"34","author":"Mazur RD","year":"2019","unstructured":"Mazur RD, Wang BA Q, Kato BS K, et al.. Effectiveness of levetiracetam monotherapy in pediatric patients with epilepsy. J Child Neurol. 2019, 34:593-7. 10.1177\/08830738198468","journal-title":"J Child Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X-ANP-2020-0082","article-title":"Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy","volume":"79","author":"Manreza ML","year":"2021","unstructured":"Manreza ML, Pan TA, Carbone EQ, et al.. Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy. Arq Neuropsiquiatr. 2021, 79:290-8. 10.1590\/0004-282X-ANP-2020-0082","journal-title":"Arq Neuropsiquiatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/jrpp.JRPP_20_53","article-title":"A comparative study on the efficacy of levetiracetam and carbamazepine in the treatment of rolandic seizures in children: An open-label randomized controlled trial","volume":"9","author":"Ahadi P","year":"2020","unstructured":"Ahadi P, Nasiri J, Ghazavi MR, Mosavian T, Mansouri V. A comparative study on the efficacy of levetiracetam and carbamazepine in the treatment of rolandic seizures in children: An open-label randomized controlled trial. J Res Pharm Pract. 2020, 9:68-72. 10.4103\/jrpp.JRPP_20_53","journal-title":"J Res Pharm Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan P","year":"2020","unstructured":"Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2020, 342:314-9. 10.1056\/NEJM200002033420503","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000217916.00225.3a","article-title":"Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures","volume":"66","author":"Glauser TA","year":"2006","unstructured":"Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, Lu Z. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology. 2006, 66:1654-60. 10.1212\/01.wnl.0000217916.00225.3a","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch BA","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A. 2004, 101:9861-6. 10.1073\/pnas.0308208101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: A review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"L\u00f6scher W","year":"2002","unstructured":"L\u00f6scher W. Basic pharmacology of valproate: A review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs. 2002, 16:669-94. 10.2165\/00023210-200216100-00003","journal-title":"CNS Drugs"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2007.0144","article-title":"Treatment of pediatric epilepsy: European expert opinion, 2007","volume":"9","author":"Wheless JW","year":"2007","unstructured":"Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord. 2007, 9:353-412. 10.1684\/epd.2007.0144","journal-title":"Epileptic Disord"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2021.12.003","article-title":"Combined effects of levetiracetam and sodium valproate on paediatric patients with epilepsy: a systematic review and meta-analysis","volume":"95","author":"Zhu Y","year":"2022","unstructured":"Zhu Y, Yang J, Zhu X. Combined effects of levetiracetam and sodium valproate on paediatric patients with epilepsy: a systematic review and meta-analysis. Seizure. 2022, 95:17-25. 10.1016\/j.seizure.2021.12.003","journal-title":"Seizure"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.22088\/cjim.13.3.617","article-title":"Efficacy of levetiracetam, lamotrigine and sodium valproate on seizure attacks and EEG disorders in patients with juvenile myoclonic epilepsy: A double blind randomized clinical trial","volume":"13","author":"Daneshyar S","year":"2022","unstructured":"Daneshyar S, Ghiasian M, Moradi S, Khanlarzadeh E. Efficacy of levetiracetam, lamotrigine and sodium valproate on seizure attacks and EEG disorders in patients with juvenile myoclonic epilepsy: A double blind randomized clinical trial. Caspian J Intern Med. 2022, 13:617-22. 10.22088\/cjim.13.3.617","journal-title":"Caspian J Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.18502\/ijph.v50i3.5593","article-title":"Comparison of the therapeutic effects of sodium valproate and levetiracetam on pediatric epilepsy and the effects of nerve growth factor and \u03b3-aminobutyric acid","volume":"50","author":"Chen M","year":"2021","unstructured":"Chen M, Jiang Y, Ma L, Zhou X, Wang N. Comparison of the therapeutic effects of sodium valproate and levetiracetam on pediatric epilepsy and the effects of nerve growth factor and \u03b3-aminobutyric acid. Iran J Public Health. 2021, 50:520-30. 10.18502\/ijph.v50i3.5593","journal-title":"Iran J Public Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-024-02987-0","article-title":"Effects of sodium valproate and levetiracetam on posterior segment parameters in children with epilepsy","volume":"44","author":"Sahin AK","year":"2024","unstructured":"Sahin AK, Cirakli S. Effects of sodium valproate and levetiracetam on posterior segment parameters in children with epilepsy. Int Ophthalmol. 2024, 44:28. 10.1007\/s10792-024-02987-0","journal-title":"Int Ophthalmol"},{"key":"ref20","article-title":"Comparison of levetiracetam and sodium valproate monotherapy in childhood epilepsy-An open label randomized trial","volume":"0","author":"Bhayana S","year":"2021","unstructured":"Bhayana S, Aggarwal A, Narang M, Sharma S, Malhotra R. Comparison of levetiracetam and sodium valproate monotherapy in childhood epilepsy-An open label randomized trial. Curr Pediatr Res. 2021, 0:","journal-title":"Curr Pediatr Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.22037\/ijcn.v17i1.21330","article-title":"Comparing prophylactic effect of levetiracetam, sodium valproate, and propranolol in pediatric migraine: A randomized clinical trial","volume":"17","author":"Fayyazi A","year":"2023","unstructured":"Fayyazi A, Pezeshki N, Mansuri H, Khajeh A. Comparing prophylactic effect of levetiracetam, sodium valproate, and propranolol in pediatric migraine: A randomized clinical trial. Iran J Child Neurol. 2023, 17:105-15. 10.22037\/ijcn.v17i1.21330","journal-title":"Iran J Child Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/387446-comparison-of-levetiracetam-versus-sodium-valproate-as-a-monotherapy-in-early-childhood-epilepsy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T11:57:34Z","timestamp":1752062254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/387446-comparison-of-levetiracetam-versus-sodium-valproate-as-a-monotherapy-in-early-childhood-epilepsy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.87574","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,9]]}}}